Epigenetics of Bladder Cancer
作者： Wun-Jae Kim , Yong-June Kim
DOI: 10.1007/978-1-61779-612-8_6
关键词: Function (biology) 、 Gene 、 Cancer research 、 Epigenetics 、 Medicine 、 Bladder cancer
摘要: Epigenetic changes are closely associated with tumor development and prognosis of bladder cancer, its detection in specimens (tissue/body fluid) may be feasible more sensitive than conventional methods. Additionally, the epigenetic interesting from a clinical point view because it possible to reverse restore gene function. markers might therefore useful molecular for detection, prediction prognosis, treatment cancer.
springer.com
springerlink.com参考文章(36)
Sabine Zöchbauer-Müller, Arthur Sagalowsky, John D. Minna, Bogdan Czerniak, Funda Vakar-Lopez, Adi F. Gazdar, Shinichi Toyooka, Arvind K. Virmani, Alfredo J. Farinas, Kiyomi O. Toyooka, Kenichi Harada, Riichiroh Maruyama, Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features Cancer Research. ,vol. 61, pp. 8659- 8663 ,(2001)
Sung-Goo Chang, Jin Il Kim, Choong-Hyun Lee, Sung-Gil Chi, Sun-Ju Lee, Hee-Yul Kim, Do-Sun Byun, Min-Goo Lee, Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Research. ,vol. 61, pp. 6688- 6692 ,(2001)
Felix Bonilla, Pilar España, Mariano Provencio, Javier Silva, Gemma Domínguez, Jose M Silva, Josefa Menéndez, Jose M García, Joaquín Carballido, p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients. Clinical Cancer Research. ,vol. 8, pp. 980- 985 ,(2002)
Stephen B. Baylln, James G. Herman, Jeremy R. Graff, Paula M. Vertino, Jean-Pierre Issa, ALTERATIONS IN DNA METHYLATION : A FUNDAMENTAL ASPECT OF NEOPLASIA Advances in Cancer Research. ,vol. 72, pp. 141- 196 ,(1998) , 10.1016/S0065-230X(08)60702-2
Wun-Jae Kim, Suk-Chul Bae, Molecular biomarkers in urothelial bladder cancer Cancer Science. ,vol. 99, pp. 646- 652 ,(2008) , 10.1111/J.1349-7006.2008.00735.X
Mohammad Obaidul Hoque, DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Review of Molecular Diagnostics. ,vol. 9, pp. 243- 257 ,(2009) , 10.1586/ERM.09.10
Carmen J. Marsit, Margaret R. Karagas, Angeline Andrew, Mei Liu, Hadi Danaee, Alan R. Schned, Heather H. Nelson, Karl T. Kelsey, Epigenetic Inactivation of SFRP Genes and TP53 Alteration Act Jointly as Markers of Invasive Bladder Cancer Cancer Research. ,vol. 65, pp. 7081- 7085 ,(2005) , 10.1158/0008-5472.CAN-05-0267
A Aleman, L Adrien, L Lopez-Serra, C Cordon-Cardo, M Esteller, T J Belbin, M Sanchez-Carbayo, Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. British Journal of Cancer. ,vol. 98, pp. 466- 473 ,(2008) , 10.1038/SJ.BJC.6604143
Jörg Ellinger, Nadja El Kassem, Lukas C. Heukamp, Swapna Matthews, Figen Cubukluoz, Philip Kahl, Frank G. Perabo, Stefan C. Müller, Alexander von Ruecker, Patrick J. Bastian, Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer Journal of Urology. ,vol. 179, pp. 346- 352 ,(2008) , 10.1016/J.JURO.2007.08.091
Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W.W. Newling, Karlheinz Kurth, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. European Urology. ,vol. 49, pp. 466- 477 ,(2006) , 10.1016/J.EURURO.2005.12.031